5 assets in Shwachman-Diamond Syndrome

Therapeutic assets addressing Shwachman-Diamond Syndrome, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Fludarabine Shwachman-Diamond Syndrome	Fred Hutchinson Cancer Center	P2/3	BB (68)
Tacrolimus Shwachman-Diamond Syndrome	Fred Hutchinson Cancer Center	P2	B (61)
Methotrexate Shwachman-Diamond Syndrome	Fred Hutchinson Cancer Center	P2	B (59)
Treosulfan Shwachman-Diamond Syndrome	Fred Hutchinson Cancer Center	P2	B (57)
Lapine T-Lymphocyte Immune Globulin Shwachman-Diamond Syndrome	Fred Hutchinson Cancer Center	P2	CCC (48)